“MULTIMODALITY TREATMENT OF GLIOBLASTOMA PATIENTS USING DIFFERENT TEMOZOLOMIDE REGIMENS IN POSTOPERATIVE CHEMORADIOTHERAPY”, Вопр. онкол., vol. 63, no. 6, pp. 915–919, Jun. 2017, doi: 10.37469/0507-3758-2017-63-6-915-919.